Hubertus Hochrein

Dr. Hubertus Hochrein


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2020 in Vaccine
Verified
Journal Article
Closed access
KSKarl Simpson
Karl Simpson
DHDavid Heymann
David Heymann
CBColin S. Brown
Colin S. Brown
WEW. John Edmunds
W. John Edmunds
JEJesper Elsgaard
Jesper Elsgaard
AWAndy Wapling
Andy Wapling

25 October 2010 in Journal of Experimental Medicine
Verified
Journal Article
Open access
HLHenning Lauterbach
Henning Lauterbach
BBBarbara Bathke
Barbara Bathke
SGStefanie Gilles
Stefanie Gilles
CTClaudia Traidl-Hoffmann
Claudia Traidl-Hoffmann
CLChristian A. Luber
Christian A. Luber
HHHubertus Hochrein
Hubertus Hochrein
Polyinosinic:polycytidylic acid (poly IC), a double-stranded RNA, is an effective adjuvant in vivo. IFN-λs (also termed IL-28/29) are potent immunomodulatory and antiviral cytokines. We demonstrate that poly IC injection in vivo induces large amounts of IFN-λ, which depended on hematopoietic cells and the presence of TLR3 (Toll-like receptor 3), IRF3 (IFN regulatory factor 3), IRF7, IFN-I receptor, Fms-related tyrosine kinase 3 ligand (FL), and IRF8 but not on MyD88 (myeloid differentiation factor 88), Rig-like helicases, or lymphocytes. Upon poly IC injection in vivo, the IFN-λ production by splenocytes segregated with cells phenotypically resembling CD8α+ conventional dendritic cells (DCs [cDCs]). In vitro experiments revealed that CD8α+ cDCs were the major producers of IFN-λ in response to poly IC, whereas both CD8α+ cDCs and plasmacytoid DCs produced large amounts of IFN-λ in response to HSV-1 or parapoxvirus. The nature of the stimulus and the cytokine milieu determined whether CD8α+ cDCs produced IFN-λ or IL-12p70. Human DCs expressing BDCA3 (CD141), which is considered to be the human counterpart of murine CD8α+ DCs, also produced large amounts of IFN-λ upon poly IC stimulation. Thus, IFN-λ production in response to poly IC is a novel function of mouse CD8α+ cDCs and their human equivalents.

13 August 2018 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
AGAmanda L. Gavin
Amanda L. Gavin
DHDeli Huang
Deli Huang
CHChristoph Huber
Christoph Huber
AMAnnica Mårtensson
Annica Mårtensson
Virginie TardifVirginie Tardif
Virginie Tardif
DNDavid Nemazee
David Nemazee

1 May 2008 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
CSChristofer Samuelsson
Christofer Samuelsson
JHJürgen Hausmann
Jürgen Hausmann
HLHenning Lauterbach
Henning Lauterbach
MSMichaela Schmidt
Michaela Schmidt
SAShizuo Akira
Shizuo Akira
HHHubertus Hochrein
Hubertus Hochrein
Poxviruses such as the causative agent of smallpox have developed multiple strategies to suppress immune responses, including the suppression of DC activation. Since poxviruses are large DNA viruses, we hypothesized that their detection by DCs may involve the endosomal DNA recognition receptor TLR9. Indeed, we have shown here that DC recognition of ectromelia virus (ECTV), the causative agent of mousepox, completely depended on TLR9. The importance of TLR9 was highlighted by the fact that mice lacking TLR9 showed drastically increased susceptibility to infection with ECTV. In contrast, we found that the strongly attenuated poxvirus modified vaccinia virus Ankara (MVA) activated DCs by both TLR9-dependent and -independent pathways. We therefore tested whether we could use the broader induction of immune responses by MVA to protect mice from a lethal infection with ECTV. Indeed, MVA given at the same time as a lethal dose of ECTV protected mice from death. Importantly, MVA also rescued TLR9-deficient mice if administered 2 full days after an otherwise lethal infection with ECTV. Therefore, these data suggest an essential role for TLR9 in the defense against poxviruses. In addition, postexposure application of MVA may protect against lethal poxvirus infection.

16 July 2018 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
OROliver Robak
Oliver Robak
Heimesaat MarkusHeimesaat Markus
Heimesaat Markus
AKAndrey Kruglov
Andrey Kruglov
SPSandra Prepens
Sandra Prepens
JNJustus Ninnemann
Justus Ninnemann
BOBastian Opitz
Bastian Opitz
Broad-spectrum antibiotics are widely used with patients in intensive care units (ICUs), many of whom develop hospital-acquired infections with Pseudomonas aeruginosa. Although preceding antimicrobial therapy is known as a major risk factor for P. aeruginosa–induced pneumonia, the underlying mechanisms remain incompletely understood. Here we demonstrate that depletion of the resident microbiota by broad-spectrum antibiotic treatment inhibited TLR-dependent production of a proliferation-inducing ligand (APRIL), resulting in a secondary IgA deficiency in the lung in mice and human ICU patients. Microbiota-dependent local IgA contributed to early antibacterial defense against P. aeruginosa. Consequently, P. aeruginosa–binding IgA purified from lamina propria culture or IgA hybridomas enhanced resistance of antibiotic-treated mice to P. aeruginosa infection after transnasal substitute. Our study provides a mechanistic explanation for the well-documented risk of P. aeruginosa infection following antimicrobial therapy, and we propose local administration of IgA as a novel prophylactic strategy.

1 January 2008
Verified
Book Chapter
Closed access
PDF file
HHHubertus Hochrein
Hubertus Hochrein
MOMeredith O'Keeffe
Meredith O'Keeffe